Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class I · High risk Ongoing Initiated Dec 15, 2025 (10 months ago)

MR. 7 SUPER 700000 capsules

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared sildenafil and tadalafil

Cause type: Chemical / undeclared

A chemical that should not be there - benzene, methanol, lead - or an undeclared prescription drug hidden in a supplement. The label gives no warning: you may be taking a toxic solvent, a heavy metal, or a drug such as sildenafil that interacts with your other medicines. All chemical / undeclared recalls.

What was recalled

MR. 7 SUPER 700000 capsules, 1 capsule blister card, Distributed by mR. 7

Recalling firm
StuffbyNainax
Origin
TX, United States
Initiated by
Voluntary: Firm initiated
Company announcement
Dec 15, 2025 · FDA notice with lot numbers
FDA recall number
D-0397-2026 · FDA notice

Treat this as urgent. Class I means FDA judged there is a reasonable probability of serious harm. Find the lot number on your package; if it matches the recalled lots, do not take another dose before you have spoken to your pharmacist or prescriber - today, not next week.

Other chemical / undeclared recalls from 2025

All chemical / undeclared recalls
Class I · High risk

SILINTAN 25/pills

Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.

Ongoing Chemical / undeclared ANTHONY TRINH, 123Herbals LLC D-0388-2026
Class I · High risk

Mojo Max Fusion XXX

Marketed Without an Approved NDA/ANDA-FDA analysis revealed undeclared sildenafil (13.1 mg/capsule) and tadalafil (13.8 mg/capsule).

Ongoing Chemical / undeclared Mohamed Hagar D-0396-2026